Full cGMP quality control analysis of clinical and commercial products is done by our in-house staff. With well-equipped, on-site analytical and microbiological laboratories as well as stability chambers, our scientists monitor end-to-end processes to confirm the safety and quality of each batch.
We implement a system-wide QbD approach to different phases of a clinical or drug product including raw materials, in-process, batch release, and stability / shelf-life evaluation.
